Growth Metrics

Akari Therapeutics (AKTX) Net Cash Flow Growth (1y) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 198.34%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 467.41%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -14,223.53%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 453.08%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -125.22%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 53.46%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -14,223.53%
Dec 31, 2025 8,963.33%
Sep 30, 2025 88.41%
Jun 30, 2025 -95.64%
Mar 31, 2025 99.33%
Dec 31, 2024 103.36%
Sep 30, 2024 21.07%
Jun 30, 2024 165.16%
Mar 31, 2024 -51.68%
Jun 30, 2023 48.65%
Mar 31, 2023 -122.80%
Jun 30, 2022 -76.21%
Mar 31, 2022 198.63%
Dec 31, 2021 110.47%
Sep 30, 2021 -110.47%
Jun 30, 2021 100.00%
Mar 31, 2021 -100.00%
Dec 31, 2020 -924,712,043.06%
Sep 30, 2020 182,479,241.34%
Jun 30, 2020 -61,865,137.94%
Mar 31, 2020 552,987,717.02%
Dec 31, 2019 83.72%
Sep 30, 2019 169.97%
Jun 30, 2019 58.27%
Mar 31, 2019 108.79%
Dec 31, 2018 50.35%
Sep 30, 2018 45.90%
Jun 30, 2018 -256.53%
Mar 31, 2018 52.06%
Dec 31, 2017 -129.79%
Sep 30, 2017 -131.52%
Jun 30, 2017 110.21%
Mar 31, 2017 -22.60%
Dec 31, 2016 390.27%
Sep 30, 2016 -105.07%
Jun 30, 2016 -4,195.73%
Mar 31, 2016 -276.30%
Dec 31, 2015 -405.38%
Sep 30, 2015 1,983.90%
Jun 30, 2015 51.16%
Mar 31, 2015 -132.22%